PCI and ACS: Where do Vorapaxar vorapaxar and bivalirudin fit in?

Naveen L. Pereira, M.D., assistant professor of medicine and pharmacology, and Gurpreet S. Sandhu, M.D., Ph.D., director of the Cardiac Catheterization Laboratory at Mayo Clinic's campus in Rochester, Minnesota, discuss adjunctive pharmacotherapy and coronary artery disease, with an emphasis on anticoagulation and antiplatelet drugs.


June 1, 2015

Created by

Mayo Clinic